The GelFix device is a one-piece posterior spinal implant made from HPAN, a biocompatible hydrogel which exhibits desirable mechanical properties including compressive resistance with a dynamic response, and is used as a spacer between the spinous processes to provide separation and prevent nerve pinching, according to the release. The implant comes in three sizes to fit the typical range of spinal stenosis patients.
The GelFix interspinous implant may not only reduce pain, but may also increase the mobility of the patient, according to the release. “The key to the procedure is the minimally invasive technique which can be used to implant the device. We insert the implant between the appropriate spinous processes and in 8-10 hours, the implant increases in size and gives us the stability that we need,” Carl Lauryssen, MD, one of Replication Medical’s surgeon advisors, said in the release.
Read the release about the GelFix Posterior Spinal Distraction implant.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
